Purchased/acquired BeautyHealth common stock or call options, or sold/wrote put options, May 10, 2022–Nov 13, 2023 and were damaged (C.D. Cal.; Alghazwi v. The Beauty Health Company)
$18M (est. ~$0.35/share before fees; $10 minimum) (total fund, not individual payout)
Who qualifies
Purchased/acquired BeautyHealth common stock or call options, or sold/wrote put options, May 10, 2022–Nov 13, 2023 and were damaged (C.D. Cal.; Alghazwi v. The Beauty Health Company)
One email when new settlements open and before deadlines close.
Free. Unsubscribe anytime.
Fund figures are total settlement funds, not individual payouts. Allegations are attributed to the underlying filings. Deadlines can change -- always confirm on the official claim site before filing.